ClinicalTrials.Veeva

Menu

: Intravascular Injection Rates During Cervical Medial Branch Block

K

Keimyung University

Status

Completed

Conditions

Vascular Complications

Treatments

Procedure: cervical spinal injection with 0.2% ropivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT05031936
2021-07-014

Details and patient eligibility

About

The purpose of this study is to compare using Toughy needle has an advantage of reducing intravascular injection rates during cervical medial branch block.

Full description

In previous reports, the use of Toughy needle was thought to reduce the incidence of intravascular injection as low as 2.9% during lumbar transforaminal injection.

Blunt needles with a pencil point tip, such as Whitacre needles, are not as sharp at their tip as are Quincke needles, which have bevels. Toughy or blunt needles may therefore be less likely to penetrate a vessel during a procedure. Hence, we postulated the incidence of intravenous uptake would be significantly lower using a Toughy needle than using a Quincke needle for lumbar medial branch block. To confirm the intravascular injection rates, we used the real time fluoroscopy after injection of contrast medium.

The goal of this study was to compare the incidence of intravascular injection rate betweeen Toughy and Quincke needles using real time fluoroscopy during cervical medial branch block

Enrollment

67 patients

Sex

All

Ages

20 to 79 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • facet joint arthropathy

Exclusion criteria

  • allergy to local anesthetics or contrast medium
  • pregnancy
  • spine deformity
  • neurologic abnormality

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

67 participants in 2 patient groups, including a placebo group

Touhy needle group
Active Comparator group
Description:
cervical medial branch block using touhy needle
Treatment:
Procedure: cervical spinal injection with 0.2% ropivacaine
Quincke needle group
Placebo Comparator group
Description:
cervical medial branch block using quincke needle
Treatment:
Procedure: cervical spinal injection with 0.2% ropivacaine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems